Cyclacel Pharmaceuticals, Inc. will undergo a 15 for 1 reverse stock split on July 7, 2025.

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) will undergo a 15 for 1 reverse stock split on July 7, 2025, to boost its stock price and comply with NASDAQ rules. Trading on a split-adjusted basis will start the same day, with the goal of attracting more investors, including institutions. The current stock price is $0.236.